文献速递胸部CT

免疫功能受损患者大型队列中耶氏肺孢子菌肺炎的胸部CT表现

Chest CT Findings of Pneumocystis jirovecii Pneumonia in a Large Cohort of Patients Who Are Immunocompromised.
PubMed 文献 · Radiol Cardiothorac Imaging · 2026-01-01

本研究为回顾性多中心研究,纳入7年间701例确诊或疑似耶氏肺孢子菌肺炎(PJP)的免疫功能受损患者,其中675例有胸部CT可复习。结果显示弥漫性磨玻璃影(GGO)是最常见表现(96.7%),且CT表现在不同免疫受损病因间高度重叠,无法区分HIV与非HIV相关免疫抑制;随访CT显示66.0%好转、25.5%加重、9.1%无变化、11.8%出现新CT模式,31.9%合并呼吸道共感染。

要点

  • PJP最常见CT表现为弥漫性分布的磨玻璃影(96.7%),无特异性征象。
  • CT表现在不同免疫受损病因间高度重叠,不能区分HIV与非HIV相关免疫抑制。
  • PJP患者中呼吸道共感染常见(31.9%),阅片时需结合临床。

核心结论

  • PJP在胸部CT上最常表现为弥漫性分布的磨玻璃影,与免疫受损病因无关;CT表现不能区分HIV与非HIV相关免疫抑制,且呼吸道共感染常见。

研究设计与样本

  • 回顾性研究,在多中心医院系统内识别7年间确诊或疑似PJP患者701例,其中675例(中位年龄65岁,IQR 54-73岁;423例男性)有胸部CT可复习,比较不同免疫受损病因间的影像特征及随访CT演变。

关键影像表现/征象

  • 弥漫性分布、无鉴别特征的磨玻璃影是最常见CT表现(96.7%),其中随机轴位分布占80.1%,外周为主占14.2%。
  • 实变见于51.1%的患者。
  • 随访CT(71.6%患者,中位间隔31天,范围2-1344天)显示PJP好转66.0%、加重25.5%、无变化9.1%、出现新CT模式11.8%。
  • PJP的CT表现在不同免疫受损病因间高度重叠,无特定病因的特异性影像模式。

临床应用与阅片要点

  • 免疫功能受损患者出现弥漫性磨玻璃影时,应将PJP纳入鉴别诊断,但CT表现不能区分HIV与非HIV相关免疫抑制。
  • 呼吸道共感染见于31.9%的患者,阅片时需结合微生物学结果综合判断。
  • 随访CT可评估PJP演变:多数(66.0%)好转,但25.5%加重、11.8%出现新CT模式,需注意动态变化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To assess chest CT imaging manifestations of Pneumocystis jirovecii pneumonia (PJP) in a large, well-characterized cohort of patients who were immunocompromised and determine whether CT findings differ by immunocompromise etiology. Materials and Methods This retrospective study identified patients with proven or probable PJP across a multicenter hospital system over a 7-year period. Available chest CT scans were reviewed for the presence and distribution of ground-glass opacity (GGO), consolidation, interlobular septal thickening, fibrosis, nodules (characterized by size and distribution), and other findings. Imaging features and their evolution at follow-up CT were compared across immunocompromise etiologies and with the overall cohort using the Fisher exact test and Kruskal-Wallis test, as applicable. Results Among 701 evaluated patients, 675 (median age, 65 years [IQR, 54-73 years]; 423 male) had chest CT examinations available for review. Immunocompromise etiologies included hematologic malignancy (32.7%), solid neoplasia receiving chemotherapy (22.5%), autoimmune disease (17.3%), solid organ transplant (13.0%), bone marrow transplant (8.3%), corticosteroid therapy (8.1%), HIV infection (7.6%), and miscellaneous causes (4.6%). Across all etiologies, diffusely distributed GGO without distinguishing features was the most common CT finding (96.7%), with a random axial distribution in 80.1% of patients and peripheral dominance in 14.2%. Consolidation was present in 51.1% of patients. PJP CT findings substantially overlapped across immunocompromise etiologies, with no imaging pattern specific to a particular etiology. Follow-up CT was available in 71.6% of patients (median interval, 31 days; range, 2-1344 days), demonstrating PJP improvement in 66.0%, worsening in 25.5%, no change in 9.1%, and new CT patterns in 11.8%. Respiratory coinfection was present in 31.9% of patients. Conclusion PJP most commonly manifested as diffusely distributed GGO on chest CT scans, regardless of the underlying cause of immunocompromise. CT findings did not distinguish between HIV- and non-HIV-related immunosuppression, and respiratory coinfection was common. Keywords: Pneumocystis jirovecii Pneumonia, Immunosuppression, Immunocompromise, CT, Ground-Glass Opacity Supplemental material is available for this article. © RSNA, 2026.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Pulsipher AM, Ham K, Vikram HR, et al. Chest CT Findings of Pneumocystis jirovecii Pneumonia in a Large Cohort of Patients Who Are Immunocompromised. Radiol Cardiothorac Imaging. 2026. PMID: 41989282. doi:10.1148/ryct.250361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。